- Hannah Ritchie and Max Roser (2018) Mental Health. Published online at OurWorldInData.org. Available from: https://ourworldindata.org/mental-health [Accessed November 2024]
You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.
UK-NOTPR-1010 | April 2022
Media relations
Lundbeck seeks an open and active dialogue with the press. Members of the press are always welcome to direct enquiries to our press contacts who work to handle them quickly and professionally.
We are always available to take your enquiries.
For UK general enquiries please give us a call at +44 1908 649966 or you can email us at united_kingdom@lundbeck.com.
Lundbeck is a global pharmaceutical company specialising in neurological and psychiatric disorders. For more than 70 years, we have been at the forefront of neuroscience research. We are dedicated to advancing brain health and transforming lives.
Millions of people worldwide are living with brain diseases.1 At Lundbeck, every day, we strive for improved treatment and a better life for people living with brain diseases.
We have approximately 5,400 employees in more than 50 countries who are engaged in the entire value chain throughout research, development, production, marketing and sales.
Our pipeline consists of several Research and Development programmes and our products are available in more than 100 countries. We have research centres in Denmark and the US and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 19.9billion in 2023.
Visit us on Instagram at @LundbeckUK and via our LundbeckUK LinkedIn page to learn more about the work we do in the UK and our focus on Brain Diseases.
70+ years
In the forefront of neuroscience research
50+
Countries of operation around the world
~5,400
Employees worldwide
19.9b DKK
Of revenue generated in 2023
UK-NOTPR-2201 | November 2024